Quality evaluation of the Japanese Adverse Drug Event Report database (JADER)-Reference-Cited by-同舟云学术

Quality evaluation of the Japanese Adverse Drug Event Report database (JADER)

Published:2019-12-10 Issue:2 Volume:29 Page:173-181
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Tsuchiya Masami¹²^ORCID,Obara Taku³⁴,Sakai Takamasa⁵,Nomura Kaori⁶,Takamura Chizuko¹,Mano Nariyasu²³

Affiliation:

1. Department of Pharmacy Miyagi Cancer Center Natori Japan

2. Laboratory of Clinical Pharmacy Tohoku University Graduate School of Pharmaceutical Sciences Sendai Japan

3. Department of Pharmaceutical Sciences Tohoku University Hospital Sendai Japan

4. Division of Preventive Medicine and Epidemiology Tohoku Medical Megabank Organization, Tohoku University Sendai Japan

5. Drug Informatics, Faculty of Pharmacy Meijo University Nagoya Japan

6. Division of Molecular Epidemiology Jikei University School of Medicine Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4944

Reference20 articles.

1. WHO Strategy for Collecting Safety Data in Public Health Programmes: Complementing Spontaneous Reporting Systems

2. Determinants of signal selection in a spontaneous reporting system for adverse drug reactions

3. Pharmaceuticals and Medical Devices Agency. Japanese adverse drug event report database.https://www.pmda.go.jp/safety/info-services/drugs/adr-info/suspected-adr/0005.html(in Japanese). Accessed April 5 2018.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeled Hepatic/Plasma Exposures of Omeprazole Prescribed Alone in Cytochrome P450 2C19 Poor Metabolizers Are Likely Associated with Hepatic Toxicity Reported in a Japanese Adverse Event Database;Biological and Pharmaceutical Bulletin;2024-05-24

2. Data-Driven Identification of Factors That Influence the Quality of Adverse Event Reports: 15-Year Interpretable Machine Learning and Time-Series Analyses of VigiBase and QUEST;JMIR Medical Informatics;2024-04-03

3. Modeled Hepatic/Plasma Exposures of Fluvastatin Prescribed Alone in Subjects with Impaired Cytochrome <i>P450 2C9*3</i> as One of Possible Determinant Factors Likely Associated with Hepatic Toxicity Reported in a Japanese Adverse Event Database;Biological and Pharmaceutical Bulletin;2024-03-15

4. An Updated Comprehensive Pharmacovigilance Study of Drug‐Induced Thrombocytopenia Based on FDA Adverse Event Reporting System Data;The Journal of Clinical Pharmacology;2024-01-05

5. A real-world disproportionality analysis of cyclosporine from the FDA Adverse Event Reporting System (FAERS) database;Brazilian Journal of Medical and Biological Research;2024